Lexotanil

Bromazepam, the active ingredient in Lexotanil, is a benzodiazepine presented as an oral formulation for oral use. It is prescribed to manage anxiety disorders and to provide short‑term relief of anxiety symptoms in adult patients.

GNH USA supplies Lexotanil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Bromazepam acts on the central nervous system to alleviate anxiety‑related conditions.

- Generalized anxiety disorder: reduces excessive worry and tension - Acute anxiety episodes: provides rapid short‑term symptom relief - Adjustment disorder with anxiety: helps normalize emotional response

Bromazepam may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued - Dizziness: sensation of light‑headedness or unsteadiness - Impaired coordination: reduced motor control and balance - Memory impairment: difficulty recalling recent events - Blurred vision: temporary visual disturbances - Fatigue: generalized lack of energy

Serious or Rare Side Effects: - Depression or suicidal thoughts: emergence of mood changes - Severe allergic reaction: rash, swelling, or breathing difficulty - Respiratory depression: slowed breathing, especially with other depressants - Paradoxical agitation: increased anxiety or aggression - Dependence or withdrawal syndrome: physical reliance after prolonged use - Hepatic dysfunction: abnormal liver enzyme elevations

When prescribing or dispensing Bromazepam, several safety considerations should be observed.

- Pregnancy: use only if clearly needed; limited safety data are available - Elderly patients: start with the lowest effective dose and monitor for sedation - History of substance abuse: assess risk of dependence and consider alternatives - Concomitant CNS depressants: increased risk of profound sedation and respiratory depression - Driving or operating machinery: advise patients that performance may be impaired - Store at room temperature: keep in the original container, protect from moisture and direct sunlight

Bromazepam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other benzodiazepines: additive central nervous system depression - Opioids: heightened risk of respiratory depression and profound sedation - Alcohol: synergistic sedative effects leading to dangerous impairment - Barbiturates: increased CNS depression and potential overdose

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may enhance serotonergic side effects - Antihistamines: can increase drowsiness and cognitive impairment - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise bromazepam plasma levels